Pelvic Organ Prolapse and Stress Urinary Incontinence treatment linked to major side effects.
Women who have had a vaginal mesh patch device implanted could be at risk for a number of internal injuries. The U.S. Food & Drug Administration (FDA) has recently released a new safety communication about the use of transvaginal mesh, typically a polypropylene implant, to treat Pelvic Organ Prolapse (POP). This mesh is also used to treat Stress Urinary Incontinence (SUI). The FDA safety communication, released on July 13, 2011, notified health care providers that the serious complications associated with surgical mesh to treat POP are “not rare.”
According to the agency, it has received 1,503 reports of complications with surgical mesh in POP patients from Jan. 1, 2008 to Dec. 31, 2010.
Transvaginal Mesh implants have been linked to a serious conditions such as extrusion of the mesh through the vaginal wall or periphery organs, chronic pain, dyspareunia (pain associated with intercourse), infections, perforations of the bowel, bladder or blood vessels, recurrence of POP and SUI, urinary problems and vaginal scarring. The implants have been known to lead to multiple surgeries down the road.
How can Transvaginal Mesh injure you and your loved ones?
Transvaginal Mesh implants can cause the above symptoms and these symptoms can be permanent as the implant is permanent. Even with future surgery it may not be possible to remove the entire mesh. Examples of transvaginal mesh and bladder sling products include Bard Avaulta, Tyco IVS, Gynecare TVT, MiniArc single incision sling, and Bard Pelvisoft, Pelviclace and Pelvicol. POP and SUI can be treated without using surgical mesh and the risks and benefits must be weighed in order to give informed consent to the procedure.
Call us with questions.
If you have questions, feel free to give us a call at 304-816-4097. We are still accepting Transvaginal Mesh cases.
Protect your rights. Get compensated for your injuries.
If you or a loved one have suffered a severe side effect as a result of a Transvaginal Mesh implant, the Manchin Inj